Peak6 Investments LLC Repligen Corp Call Options Transaction History

Peak6 Investments LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $351,700 - $470,050	-2,500 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $2.16 Million - $3.46 Million	-13,400 Reduced 84.28%	2,500 $470,000
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $5 Million - $6.15 Million	-20,200 Reduced 55.96%	15,900 $4.21 Million
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $4.11 Million - $6.84 Million	21,100 Added 140.67%	36,100 $10.4 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $1.41 Million - $2.11 Million	15,000 New	15,000 $1.85 Million
Q3 2019 Nov 08, 2019	SELL	$76.65 - $95.51 $1.67 Million - $2.08 Million	-21,800 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $1.18 Million - $1.87 Million	21,800 New	21,800 $1.87 Million
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $1.3 Million - $1.65 Million	-26,200 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$48.26 - $68.88 $1.52 Million - $2.16 Million	-31,400 Reduced 54.51%	26,200 $1.38 Million
Q3 2018 Nov 13, 2018	BUY	$46.8 - $58.97 $2.7 Million - $3.4 Million	57,600 New	57,600 $3.19 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.